ZA895010B - Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion - Google Patents

Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion

Info

Publication number
ZA895010B
ZA895010B ZA895010A ZA895010A ZA895010B ZA 895010 B ZA895010 B ZA 895010B ZA 895010 A ZA895010 A ZA 895010A ZA 895010 A ZA895010 A ZA 895010A ZA 895010 B ZA895010 B ZA 895010B
Authority
ZA
South Africa
Prior art keywords
interferion
podophyllin
treatment
combination
recombinant dna
Prior art date
Application number
ZA895010A
Other languages
English (en)
Inventor
Edwin A Peets
A Peets Edwin
Eugene L Taylor
L Taylor Eugene
Kenneth A Smiles
A Smiles Kenneth
Daniel J Tanner
J Tanner Daniel
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA895010B publication Critical patent/ZA895010B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA895010A 1988-07-05 1989-06-30 Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion ZA895010B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21501388A 1988-07-05 1988-07-05

Publications (1)

Publication Number Publication Date
ZA895010B true ZA895010B (en) 1990-03-28

Family

ID=22801283

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895010A ZA895010B (en) 1988-07-05 1989-06-30 Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion

Country Status (7)

Country Link
EP (2) EP0351974A1 (xx)
JP (1) JPH0618784B2 (xx)
KR (1) KR900701322A (xx)
AU (1) AU3857389A (xx)
CA (1) CA1336492C (xx)
WO (1) WO1990000406A1 (xx)
ZA (1) ZA895010B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100415A0 (en) * 1990-12-21 1992-09-06 Schering Corp Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
CN1048688C (zh) * 1991-07-29 2000-01-26 麦唐纳·威塞斯·赫尤斯股份有限公司 污染性垃圾收集器
US20200038487A1 (en) 2017-03-31 2020-02-06 Accanis Biotech F&E Gmbh & Co Kg Prevention and treatment of non-melanoma skin cancer (nmsc)
US20200390688A1 (en) * 2019-06-14 2020-12-17 Piedmont Animal Health Inc. Long-acting topical formulation and method of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307614D0 (en) * 1983-03-18 1983-04-27 Pharma Medica As Treatment of genital warts
JPS59175416A (ja) * 1983-03-25 1984-10-04 Sunstar Inc 皮膚および粘膜の角化異常治療用外用剤
CA1321347C (en) * 1986-11-10 1993-08-17 David C. Munch Human leukocyte interferon composition and skin treatment

Also Published As

Publication number Publication date
JPH0618784B2 (ja) 1994-03-16
JPH03501734A (ja) 1991-04-18
WO1990000406A1 (en) 1990-01-25
KR900701322A (ko) 1990-12-01
EP0351974A1 (en) 1990-01-24
AU3857389A (en) 1990-02-05
CA1336492C (en) 1995-08-01
EP0423191A1 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
GB2221390B (en) Niacin-containing composition and its therapeutic use
EP0573275A3 (en) High efficiency tissue stimulating and signal sensing electrode
SG49658A1 (en) Treatment of condition and disease
EP0219458A3 (en) Medicament adsorbates and their preparation
IL89885A0 (en) Fibrin-collagen tissue equivalents and their production
AU4403789A (en) Upper and lower body exerciser
EP0333344A3 (en) Corneal implants and manufacture and use thereof
EP0422623A3 (en) Enzymatic electrode and its use
AR243240A1 (es) Procedimiento para preparar una proteina con actividad de factor estimulador de colonia y acido nucleico que comprende una secuencia nucleotidica capaz de modificarla.
IL90690A0 (en) Tissue equivalents and their preparation
JPS6487537A (en) Transparent body and manufacture
EP0351314A3 (en) Medical material and medical implement
EP0506893A4 (en) Diagnosis and treatment of diseases
GB2184653B (en) Dementia-improving and therapeutic agents
ZA898234B (en) Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon
ZA895010B (en) Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion
EP0294538A3 (en) Use of nigericin in the treatment of viral diseases
EP0404834A4 (en) Squalene oxide cyclase inhibitors and therapeutic use thereof
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
IL88262A0 (en) Factors associated with essential hypertension and derivatives thereof and their diagnostic and therapeutic use
GB2220652B (en) Treatment of pastures
GR871634B (en) Therapeutic mean and its usage
GB2211735B (en) Metoprolol in the treatment and prophylaxis of heart disease
SG130694G (en) Peptide fragments of hiv and their use in vaccines and diagnosis
IE893500L (en) Treating genital warts with liquid nitrogen and human alpha¹interferon